Clinical Efficacy and Safety Evaluation on the Addition Phacoemulsification, Intraocular Lens Implantation and Trabeculectomy for the Treatment of Cataract Combined with Glaucoma

Objective: To investigate the clinical efficacy and safety about the additional phacoemulsification, intraocular lens implantation and trabeculectomy on the treatment of cataract combined with glaucoma. Methods: 100 cases of cataract combined with glaucoma who were selected and randomly divided into the control group and the observation group according to the law of draw. Patients of the control group were treated by the simple phacoemulsification and intraocular lens implantation, while the patients in the observation group were given trabeculectomy besides the basic methods. The relative indexes and the average incidence of postoperative complications etc. were compared before and after the treatment. Results:(1) There was no statistically significant difference of the control group before and after treatment in terms of the IOP, ACD and AL; There were statistically significant differences in terms of the CAD and IOP in the observation group before and after treatment(P0.05); but there was no significant difference about AL before and after treatment.(2) Preoperative and postoperative 1week, 1month and 3month average value of visual field defects, the average pattern standard deviation, the differences were statistically significant, and there were statistical difference between the two groups between the two groups.(3) The complication rate in the control group was 20.00%, which was significantly higher than that of the observation group(10.00%). Conclusion: The phacoemulsification, intraocular lens implantation and trabeculectomy of cataract combined with glaucoma has a significant effect, low incidence of adverse reactions, and it is worthy to be promoted and applied clinically.